The British government announced an indefinite ban on puberty blockers for under-18s with gender dysphoria, except in clinical trials, due to safety concerns.
Wes Streeting emphasized the need for caution when dealing with vulnerable youth, stating that the decision follows expert medical advice regarding the safety risks of puberty blockers.
A clinical trial is being set up next year to establish a clear evidence base for the use of puberty blockers, addressing concerns highlighted in a recent review.
The restrictions follow a report by pediatrician Hilary Cass, which noted that gender medicine lacks solid evidence, raising significant concerns about the treatment of minors.
Collection
[
|
...
]